acetylcysteine has been researched along with Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donida, B; Dos Reis, BG; Faverzani, JL; Hammerschmidt, TG; Kessler, RG; Machado, AZ; Moura, AP; Moura, DJ; Reinhardt, LS; Sebastião, FM; Vargas, CR | 1 |
| Donida, B; Ferro, MB; Giugliani, R; Guerreiro, GB; Hammerschmidt, TG; Kessler, RG; Moura, DJ; Raabe, M; Vargas, CR | 1 |
| Baxter, LL; Firnkes, S; Fu, R; Graham, M; Incao, A; Liscum, L; Ory, DS; Pavan, WJ; Porter, FD; Sidhu, R; Wassif, CA; Watkins-Chow, DE; Yanjanin, NM | 1 |
| Bembi, B; Buratti, E; Canterini, S; Dardis, A; Fiorenza, MT; Ghetti, B; Murrell, JR; Newell, KL; Stuani, C; Zampieri, S | 1 |
| Alarcon-Vila, C; Balboa, E; Baulies, A; Caballeria, J; Casas, J; Enrich, C; Fabrías, G; Fernandez, A; Fernández-Checa, JC; Garcia-Rovés, P; Garcia-Ruiz, C; Gonzalez-Franquesa, A; Levade, T; Martinez, L; Matías, N; Nuñez, S; Nuño, N; Torres, S; Zanlungo, S | 1 |
1 trial(s) available for acetylcysteine and Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia
| Article | Year |
|---|---|
Efficacy of N-acetylcysteine in phenotypic suppression of mouse models of Niemann-Pick disease, type C1.
Topics: Acetylcysteine; Adolescent; Adult; Animals; Child; Child, Preschool; Cross-Over Studies; Disease Models, Animal; Double-Blind Method; Female; Gene Expression; Humans; Liver; Male; Mice; Mice, Knockout; Niemann-Pick Disease, Type C; Oxidative Stress; Ubiquinone; Young Adult | 2013 |
4 other study(ies) available for acetylcysteine and Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia
| Article | Year |
|---|---|
Cytokine profile and cholesterol levels in patients with Niemann-Pick type C disease presenting neurological symptoms: in vivo effect of miglustat and in vitro effect of N-acetylcysteine and coenzyme Q10.
Topics: 1-Deoxynojirimycin; Acetylcysteine; Antioxidants; Cholesterol; Cytokines; Enzyme Inhibitors; Humans; Inflammation; Niemann-Pick Disease, Type C; Ubiquinone | 2022 |
Beneficial in vitro effect of N-acetylcysteine and coenzyme Q10 on DNA damage in neurodegenerative Niemann-Pick type C 1 disease: preliminary results.
Topics: Acetylcysteine; Antioxidants; DNA Damage; Humans; Niemann-Pick Disease, Type C | 2023 |
Altered localization and functionality of TAR DNA Binding Protein 43 (TDP-43) in niemann- pick disease type C.
Topics: Acetylcysteine; Animals; beta-Cyclodextrins; Brain; Cell Nucleus; Cells, Cultured; Disease Models, Animal; DNA-Binding Proteins; Fibroblasts; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice, Inbred BALB C; Mice, Transgenic; Middle Aged; Neurons; Neuroprotective Agents; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Proteins; Spinal Cord | 2016 |
Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.
Topics: Acetylcysteine; Animals; Cerebellum; Cholesterol; Glutathione; Humans; Intracellular Signaling Peptides and Proteins; Lysosomes; Mice; Mice, Knockout; Mitochondria; Mutation; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Oxidative Phosphorylation; Proteins; Purkinje Cells; Vesicular Transport Proteins | 2017 |